Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1992 May;65(5):698–702. doi: 10.1038/bjc.1992.147

Tumour growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry.

G Forster 1, T G Cooke 1, L D Cooke 1, P D Stanton 1, G Bowie 1, P M Stell 1
PMCID: PMC1977390  PMID: 1586597

Abstract

The cell kinetics of 82 squamous cell carcinomas of the head and neck were studied by in vivo administration of the thymidine analogue, bromodeoxyuridine (BrdUrd). Ploidy, BrdUrd labelling index (LI), duration of S-phase (Ts), potential doubling time (Tpot) and S-phase fraction (SPF) were measured by flow cytometry on 50 microns paraffin embedded sections. The range of values obtained compared well with other in vivo cell kinetic studies of head and neck cancer. Aneuploid tumours had a significantly higher BrdUrd labelling index and SPF, and a short Tpot than diploid tumours. To validate the use of 50 microns sections for measuring cell kinetic parameters by flow cytometry a comparison of values obtained by 50 microns sections and small blocks of tissue was made. No significant difference was found between the two methods. Reproducibility of values between two consecutive thick sections was also good. We conclude that reproducible cell kinetic measurements can be made in tumour samples using 50 microns sections of BrdUrd labelled tissue.

Full text

PDF
700

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison D. C., Ridolpho P. F., Anderson S., Bose K. Variations in the [3H]thymidine labeling of S-phase cells in solid mouse tumors. Cancer Res. 1985 Dec;45(12 Pt 1):6010–6016. [PubMed] [Google Scholar]
  2. Armitage N. C., Robins R. A., Evans D. F., Turner D. R., Baldwin R. W., Hardcastle J. D. The influence of tumour cell DNA abnormalities on survival in colorectal cancer. Br J Surg. 1985 Oct;72(10):828–830. doi: 10.1002/bjs.1800721018. [DOI] [PubMed] [Google Scholar]
  3. Barlogie B., Stass S., Dixon D., Keating M., Cork A., Trujillo J. M., McCredie K. B., Freireich E. J. DNA aneuploidy in adult acute leukemia. Cancer Genet Cytogenet. 1987 Oct;28(2):213–228. doi: 10.1016/0165-4608(87)90207-x. [DOI] [PubMed] [Google Scholar]
  4. Begg A. C., Hofland I., Moonen L., Bartelink H., Schraub S., Bontemps P., Le Fur R., Van Den Bogaert W., Caspers R., Van Glabbeke M. The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report. Int J Radiat Oncol Biol Phys. 1990 Dec;19(6):1449–1453. doi: 10.1016/0360-3016(90)90357-p. [DOI] [PubMed] [Google Scholar]
  5. Begg A. C., McNally N. J., Shrieve D. C., Kärcher H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry. 1985 Nov;6(6):620–626. doi: 10.1002/cyto.990060618. [DOI] [PubMed] [Google Scholar]
  6. Bland J. M., Altman D. G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986 Feb 8;1(8476):307–310. [PubMed] [Google Scholar]
  7. Brandt L., Olsson H. Survival following combination chemotherapy in advanced high grade non-Hodgkin's lymphomas: relation to proliferative activity of the lymphoma cells. Eur J Haematol. 1987 May;38(5):437–441. doi: 10.1111/j.1600-0609.1987.tb01441.x. [DOI] [PubMed] [Google Scholar]
  8. Bresciani F., Paoluzi R., Benassi M., Nervi C., Casale C., Ziparo E. Cell kinetics and growth of squamous cell carcinomas in man. Cancer Res. 1974 Sep;34(9):2405–2415. [PubMed] [Google Scholar]
  9. Chauvel P., Courdi A., Gioanni J., Vallicioni J., Santini J., Demard F. The labelling index: a prognostic factor in head and neck carcinoma. Radiother Oncol. 1989 Mar;14(3):231–237. doi: 10.1016/0167-8140(89)90171-0. [DOI] [PubMed] [Google Scholar]
  10. Chavaudra N., Richard J. M., Malaise E. P. Labelling index of human squamous cell carcinomas. Comparison of in vivo and in vitro labelling methods. Cell Tissue Kinet. 1979 Mar;12(2):145–152. doi: 10.1111/j.1365-2184.1979.tb00121.x. [DOI] [PubMed] [Google Scholar]
  11. Cooke L. D., Cooke T. G., Bootz F., Forster G., Helliwell T. R., Spiller D., Stell P. M. Ploidy as a prognostic indicator in end stage squamous cell carcinoma of the head and neck region treated with cisplatinum. Br J Cancer. 1990 May;61(5):759–762. doi: 10.1038/bjc.1990.169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cornelisse C. J., van de Velde C. J., Caspers R. J., Moolenaar A. J., Hermans J. DNA ploidy and survival in breast cancer patients. Cytometry. 1987 Mar;8(2):225–234. doi: 10.1002/cyto.990080217. [DOI] [PubMed] [Google Scholar]
  13. Courdi A., Héry M., Dahan E., Gioanni J., Abbes M., Monticelli J., Ettore F., Moll J. L., Namer M. Factors affecting relapse in node-negative breast cancer. A multivariate analysis including the labeling index. Eur J Cancer Clin Oncol. 1989 Feb;25(2):351–356. doi: 10.1016/0277-5379(89)90029-1. [DOI] [PubMed] [Google Scholar]
  14. Denekamp J., Kallman R. F. In vitro and in vivo labelling of animal tumours with tritiated thymidine. Cell Tissue Kinet. 1973 May;6(3):217–227. doi: 10.1111/j.1365-2184.1973.tb01611.x. [DOI] [PubMed] [Google Scholar]
  15. Dolbeare F., Gratzner H., Pallavicini M. G., Gray J. W. Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci U S A. 1983 Sep;80(18):5573–5577. doi: 10.1073/pnas.80.18.5573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Feichter G. E., Maier H., Adler D., Born I. A., Abel U., Haag D., Goerttler K. S-phase fractions and DNA-ploidy of oropharyngeal squamous epithelium carcinomas compared with histologic grade, stage, response to chemotherapy and survival. Acta Otolaryngol. 1987 Sep-Oct;104(3-4):377–384. doi: 10.3109/00016488709107343. [DOI] [PubMed] [Google Scholar]
  17. Franzén G., Klintenberg C., Olofsson J., Risberg B. DNA measurement--an objective predictor of response to irradiation? A review of 24 squamous cell carcinomas of the oral cavity. Br J Cancer. 1986 May;53(5):643–651. doi: 10.1038/bjc.1986.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Friedlander M. L., Hedley D. W., Taylor I. W., Russell P., Coates A. S., Tattersall M. H. Influence of cellular DNA content on survival in advanced ovarian cancer. Cancer Res. 1984 Jan;44(1):397–400. [PubMed] [Google Scholar]
  19. Gentili C., Sanfilippo O., Silvestrini R. Cell proliferation and its relationship to clinical features and relapse in breast cancers. Cancer. 1981 Aug 15;48(4):974–979. doi: 10.1002/1097-0142(19810815)48:4<974::aid-cncr2820480420>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  20. Gratzner H. G. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science. 1982 Oct 29;218(4571):474–475. doi: 10.1126/science.7123245. [DOI] [PubMed] [Google Scholar]
  21. Guo Y. C., DeSanto L., Osetinsky G. V. Prognostic implications of nuclear DNA content in head and neck cancer. Otolaryngol Head Neck Surg. 1989 Feb;100(2):95–98. doi: 10.1177/019459988910000203. [DOI] [PubMed] [Google Scholar]
  22. Hedley D. W., Friedlander M. L., Taylor I. W. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance. Cytometry. 1985 Jul;6(4):327–333. doi: 10.1002/cyto.990060409. [DOI] [PubMed] [Google Scholar]
  23. Holm L. E. Cellular DNA amounts of squamous cell carcinomas of the head and neck region in relation to prognosis. Laryngoscope. 1982 Sep;92(9 Pt 1):1064–1069. [PubMed] [Google Scholar]
  24. Meyer J. S., Bauer W. C. In vitro determination of tritiated thymidine labeling index (LI). Evaluation of a method utilizing hyperbaric oxygen and observations on the LI of human mammary carcinoma. Cancer. 1975 Oct;36(4):1374–1380. doi: 10.1002/1097-0142(197510)36:4<1374::aid-cncr2820360428>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  25. Meyer J. S. Cell kinetic measurements of human tumors. Hum Pathol. 1982 Oct;13(10):874–877. doi: 10.1016/s0046-8177(82)80045-2. [DOI] [PubMed] [Google Scholar]
  26. Meyer J. S., Hixon B. Advanced stage and early relapse of breast carcinomas associated with high thymidine labeling indices. Cancer Res. 1979 Oct;39(10):4042–4047. [PubMed] [Google Scholar]
  27. Sakuma J. Cell kinetics of human squamous cell carcinomas in the oral cavity. Bull Tokyo Med Dent Univ. 1980 Mar;27(1):43–54. [PubMed] [Google Scholar]
  28. Saunders M. I., Dische S. Radiotherapy employing three fractions in each day over a continuous period of 12 days. Br J Radiol. 1986 May;59(701):523–525. doi: 10.1259/0007-1285-59-701-523. [DOI] [PubMed] [Google Scholar]
  29. Silvestrini R., Molinari R., Costa A., Volterrani F., Gardani G. Short-term variation in labeling index as a predictor of radiotherapy response in human oral cavity carcinoma. Int J Radiat Oncol Biol Phys. 1984 Jul;10(7):965–970. doi: 10.1016/0360-3016(84)90164-0. [DOI] [PubMed] [Google Scholar]
  30. Steel G. G., Bensted J. P. In vitro studies of cell proliferation in tumours. I. Critical appraisal of methods and theoretical considerations. Eur J Cancer. 1965 Nov;1(3):275–279. doi: 10.1016/0014-2964(65)90060-5. [DOI] [PubMed] [Google Scholar]
  31. Thames H. D., Jr, Peters L. J., Withers H. R., Fletcher G. H. Accelerated fractionation vs hyperfractionation: rationales for several treatments per day. Int J Radiat Oncol Biol Phys. 1983 Feb;9(2):127–138. doi: 10.1016/0360-3016(83)90089-5. [DOI] [PubMed] [Google Scholar]
  32. Trott K. R., Kummermehr J. What is known about tumour proliferation rates to choose between accelerated fractionation or hyperfractionation? Radiother Oncol. 1985 Jan;3(1):1–9. doi: 10.1016/s0167-8140(85)80002-5. [DOI] [PubMed] [Google Scholar]
  33. Volm M., Mattern J., Sonka J., Vogt-Schaden M., Wayss K. DNA distribution in non-small-cell lung carcinomas and its relationship to clinical behavior. Cytometry. 1985 Jul;6(4):348–356. doi: 10.1002/cyto.990060412. [DOI] [PubMed] [Google Scholar]
  34. Wilson G. D., McNally N. J., Dunphy E., Kärcher H., Pfragner R. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry. Cytometry. 1985 Nov;6(6):641–647. doi: 10.1002/cyto.990060621. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES